Learning Objectives: At the completion of this activity, participants will be able to:

1. Recognize the lack of evidence of accuracy and effectiveness of these multi‐cancer early detection screening tools, known
as “liquid biopsies.”
2. Discuss with patients seeking these tests the limitations (very limited benefits) of these tests through a process of shared
decision making.
3. Recognize the ethical problems (limited patient benefit, unjust social costs) associated with these tests.